Takafumi Naito Selected Research

noroxycodone

12/2016	Relationships between oxycodone pharmacokinetics, central symptoms, and serum interleukin-6 in cachectic cancer patients.
11/2011	CYP3A5*3 affects plasma disposition of noroxycodone and dose escalation in cancer patients receiving oxycodone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takafumi Naito Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 11/2011
6	Cachexia 01/2022 - 10/2012
6	Colorectal Neoplasms (Colorectal Cancer) 08/2015 - 04/2014
5	Inflammation (Inflammations) 01/2022 - 02/2015
5	Cancer Pain 06/2016 - 10/2012
4	Rheumatoid Arthritis 07/2019 - 04/2011
4	Body Weight (Weight, Body) 07/2017 - 01/2013
3	Heart Failure 08/2022 - 01/2019
3	Head and Neck Neoplasms (Head and Neck Cancer) 03/2021 - 11/2017
3	Nausea 01/2019 - 02/2014
2	Pain (Aches) 01/2019 - 10/2016
2	Vomiting 05/2018 - 02/2014
2	Birth Weight (Birth Weights) 07/2017 - 05/2015
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2017 - 01/2011
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 12/2015 - 05/2015
2	Neoplasm Metastasis (Metastasis) 10/2014 - 11/2012
2	Adenoma (Adenomas) 08/2014 - 04/2014
2	Lupus Nephritis 12/2010 - 12/2008
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Exanthema (Rash) 01/2021
1	Atrial Fibrillation 06/2020
1	Hypertension (High Blood Pressure) 07/2019
1	Lung Diseases (Lung Disease) 01/2019
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2019
1	Skin Neoplasms (Skin Cancer) 01/2018
1	Bacterial Vaginosis 07/2017
1	Sleepiness 12/2016
1	Lung Neoplasms (Lung Cancer) 05/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2015
1	Adenocarcinoma 12/2014

Drug/Important Bio-Agent (IBA)

14	Cytochrome P-450 CYP3AIBA 08/2022 - 11/2011
7	Oxycodone (Oxycontin)FDA LinkGeneric 01/2019 - 11/2011
5	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 03/2021 - 11/2011
5	Opioid Analgesics (Opioids)IBA 10/2019 - 10/2012
5	Tacrolimus (Prograf)FDA LinkGeneric 07/2019 - 12/2010
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2016
4	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2021 - 01/2013
4	Tramadol (K315)FDA LinkGeneric 03/2021 - 01/2016
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2017 - 12/2008
4	Fentanyl (Sublimaze)FDA LinkGeneric 06/2016 - 01/2012
3	Tolvaptan FDA Link 08/2022 - 01/2019
3	Voriconazole (Vfend)FDA LinkGeneric 05/2021 - 01/2018
3	Pharmaceutical PreparationsIBA 05/2021 - 10/2016
3	Amlodipine (Norvasc)FDA LinkGeneric 07/2019 - 05/2015
3	Prochlorperazine (Compazine)FDA LinkGeneric 01/2019 - 02/2014
3	GlucuronidesIBA 07/2017 - 12/2008
3	Biomarkers (Surrogate Marker)IBA 03/2015 - 04/2014
3	Calcibiotic Root Canal SealerIBA 12/2014 - 04/2014
2	Aprepitant (Emend)FDA Link 01/2021 - 01/2013
2	Cetuximab (Erbitux)FDA Link 01/2021 - 11/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 08/2015
2	Pregabalin (Lyrica)FDA Link 10/2019 - 10/2016
2	Prednisolone (Predate)FDA LinkGeneric 07/2019 - 01/2019
2	AntiemeticsIBA 01/2019 - 05/2018
2	EnzymesIBA 01/2018 - 04/2011
2	Inosine FDA Link 07/2017 - 12/2010
2	Oxidoreductases (Dehydrogenase)IBA 07/2017 - 12/2010
2	noroxycodoneIBA 12/2016 - 11/2011
2	MicroRNAs (MicroRNA)IBA 09/2014 - 04/2014
2	TabletsIBA 10/2012 - 11/2011
1	Amiodarone (Amiodarona)FDA LinkGeneric 08/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	NivolumabIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	CytochromesIBA 05/2021
1	C-Reactive ProteinIBA 05/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	edoxabanIBA 06/2020
1	SodiumIBA 04/2020
1	Biological ProductsIBA 07/2019
1	Antirheumatic Agents (DMARD)IBA 07/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Dacarbazine (DIC)FDA LinkGeneric 01/2019
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2019
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2019
1	5-diazoimidazole-4-carboxamideIBA 01/2019
1	Cytochrome P-450 CYP2C19IBA 05/2018
1	ProlactinIBA 05/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2018
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2018
1	Chloramphenicol (Chloromycetin)FDA Link 07/2017
1	Complement System Proteins (Complement)IBA 07/2017
1	CytokinesIBA 12/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2015
1	GlucocorticoidsIBA 02/2015
1	TriazolesIBA 02/2015
1	Analgesics (Analgesic Drugs)IBA 01/2015
1	Keratin-7 (Cytokeratin 7)IBA 12/2014
1	VimentinIBA 12/2014

Therapy/Procedure

7	Therapeutics 07/2017 - 11/2012
3	Drug Therapy (Chemotherapy) 10/2014 - 11/2012
2	Radiotherapy 10/2014 - 11/2012
2	Kidney Transplantation 12/2010 - 12/2008
1	Intravenous Infusions 01/2019
1	Chemoprevention 01/2018
1	Pancreaticoduodenectomy 12/2014